Roles of nuclear receptors in the gene expression of drug-metabolizing enzymes under various physiological conditions

被引:2
|
作者
Yoshinari, Kouichi [1 ]
机构
[1] Univ Shizuoka, Sch Pharmaceut Sci, Dept Pharmacobiochem, Suruga Ku, Shizuoka 4228526, Japan
关键词
cytochrome P450; nuclear receptor; constitutive androstane receptor; model animal; nuclear translocation; obesity;
D O I
10.1248/yakushi.126.343
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The nuclear receptor constitutive androstane receptor (CAR), a key transcription factor for the expression of cytochrome P450 (CYP) 2B genes, resides in the cytoplasm under untreated conditions and translocates into the nucleus upon xenobiotic exposure. CAR forms a multiprotein complex including heat shock protein 90 in the cytoplasm as the glucocorticoid receptor, and it is likely that protein phosphatase 2A plays a critical role in the first step of CAR nuclear translocation. In addition to the xenobiotic induction of CYP2Bs, our recent studies have indicated that CAR is important for sex and strain differences and obesity/ diabetes-associated changes in the expression of CYP2B genes. These results have raised the hypothesis that the expression of nuclear receptors varies depending on the physiologic condition, leading to the dysregulation of CYP expression. In obese mice fed a high-fat diet, however, hepatic CYP3A levels are drastically decreased without any significant changes in the expression of nuclear receptors including the pregnane X receptor and hepatocyte nuclear factor-4, which are known to be key transcription factors in the expression of CYP3A genes. These results indicate that it is important to investigate the mechanism of the transcriptional regulation of nuclear receptor genes as well as the activation of nuclear receptors to understand the CYP expression system fully.
引用
收藏
页码:343 / 348
页数:6
相关论文
共 50 条
  • [41] Regulation of brain drug metabolizing enzymes and transporters by nuclear receptors
    Xu, Dan
    Huang, Songqiang
    Wang, Hui
    Xie, Wen
    DRUG METABOLISM REVIEWS, 2018, 50 (04) : 407 - 414
  • [42] Regulation of cutaneous drug-metabolizing enzymes and cytoprotective gene expression by topical drugs in human skin in vivo
    Smith, G.
    Ibbotson, S. H.
    Comrie, M. M.
    Dawe, R. S.
    Bryden, A.
    Ferguson, J.
    Wolf, C. R.
    BRITISH JOURNAL OF DERMATOLOGY, 2006, 155 (02) : 275 - 281
  • [43] Phenotypic Models of Drug-Drug-Gene Interactions Mediated by Cytochrome Drug-Metabolizing Enzymes
    Viviani, Roberto
    Berres, Judith
    Stingl, Julia C.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 116 (03) : 592 - 601
  • [44] Sex-and age-dependent gene expression in human liver: An implication for drug-metabolizing enzymes
    Uno, Yasuhiro
    Takata, Ryo
    Kito, Go
    Yamazaki, Hiroshi
    Nakagawa, Kazuko
    Nakamura, Yusuke
    Kamataki, Tetsuya
    Katagiri, Toyomasa
    DRUG METABOLISM AND PHARMACOKINETICS, 2017, 32 (01) : 100 - 107
  • [45] Increased gene expression of hepatic drug-metabolizing enzymes by repetitive treatment with nicardipine in spontaneously hypertensive rats
    Kinae, Y.
    Miyajima, S.
    Sekimoto, M.
    Nemoto, K.
    Degawa, M.
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2007, 29 (04) : 248 - 248
  • [46] Expression of intestinal drug-metabolizing enzymes in patients with chronic inflammatory bowel disease
    Klotz, U
    Hoensch, H
    Schutz, T
    Beaune, P
    Zanger, U
    Bode, JC
    Fritz, P
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1998, 59 (08): : 556 - 563
  • [47] Heterogeneous expression of drug-metabolizing enzymes in human biliary epithelial cells.
    Lakehal, F
    Wendum, D
    Beaune, P
    Ballet, F
    Poupon, R
    Housset, C
    HEPATOLOGY, 1997, 26 (04) : 1075 - 1075
  • [48] Activation of MAPKs influences the expression of drug-metabolizing enzymes in primary human hepatocytes
    Bachleda, Petr
    Vrzal, Radim
    Dvorak, Zdenek
    GENERAL PHYSIOLOGY AND BIOPHYSICS, 2009, 28 (03) : 316 - 320
  • [49] Expression and transcriptional activities of nuclear receptors involved in regulation of drug-metabolizing enzymes are not altered by colchiceine:: Focus on PXR, CAR, and GR in primary human hepatocytes
    Dvorak, Z.
    Maurel, P.
    Vilarem, M-J
    Ulrichova, J.
    Modriansky, M.
    CELL BIOLOGY AND TOXICOLOGY, 2007, 23 (02) : 63 - 73
  • [50] IN-VITRO EXPRESSION OF DRUG-METABOLIZING ENZYME-ACTIVITIES IN HUMAN ADULT KERATINOCYTES UNDER VARIOUS CULTURE CONDITIONS AND THEIR RESPONSE TO INDUCERS
    HIREL, B
    CHESNE, C
    PAILHERET, JP
    GUILLOUZO, A
    TOXICOLOGY IN VITRO, 1995, 9 (01) : 49 - 56